Value Sense
DGX
Quest Diagnostics Incorporated (DGX)
Last Price$177.02.3%
Market Cap$19.6B
Intrinsic value score
6/10
Good
Intrinsic value
$369.8
DCF value - $331.1 Relative value - $408.5
Undervalued
109.0%
LTM P/E
22.5x
Peer set median 31.3x
Discount rate
5.8%
DGX
is 109.0% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

DGX Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 DGX Relative Value is $409.5, which is undervalued by 131.4%, compared to current share price of $177.0.
DCF Value vs Current Share Price
As of Mar 03, 2025 DGX DCF Value is $331.0, which is undervalued by 87.1%, compared to current share price of $177.0.
Methodology
Price per share, $
DGX
Intrinsic value$369.8
Undervalued by109.0%
Current share price
177.0
Relative value
409.5
DCF value
331.0

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

DGX Historical Intrinsic Value

Crunching data... Almost there!

DGX vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Quest Diagnostics Incorporated logo
Quest Diagnostics IncorporatedDGX
109.0%
(6.4%)
(6.5%)
9.2%
Median Peer Set
(0.3%)
(2.7%)
15.2%
Natera, Inc. logo
Natera, Inc.NTRA
(50.4%)
32.0%
(32.1%)
(40.2%)
IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc.IDXX
(49.8%)
8.7%
25.2%
23.1%
Waters Corporation logo
Waters CorporationWAT
(36.5%)
(0.5%)
(7.9%)
21.7%
Mettler-Toledo International Inc. logo
Mettler-Toledo International Inc.MTD
(31.5%)
2.2%
12.7%
22.3%
Danaher Corporation logo
Danaher CorporationDHR
(18.8%)
(0.1%)
(17.9%)
16.3%
Agilent Technologies, Inc. logo
Agilent Technologies, Inc.A
(17.9%)
(4.7%)
5.0%
19.8%
Thermo Fisher Scientific Inc. logo
Thermo Fisher Scientific Inc.TMO
15.0%
(4.6%)
(12.4%)
14.0%
IQVIA Holdings Inc. logo
IQVIA Holdings Inc.IQV
63.0%
2.8%
2.4%
8.9%
Illumina, Inc. logo
Illumina, Inc.ILMN
74.8%
(2.9%)
4.6%
(28.0%)
Laboratory Corporation of America Holdings logo
Laboratory Corporation of America HoldingsLH
144.4%
(18.3%)
(65.8%)
3.4%

Explore more intrinsic value tools hub for DGX

Peter Lynch Fair Value
Intrinsic Value
Earnings Power Value
Ben Graham Fair Value
Earnings growth model
DCF value calculator
Discount rate
Peter Lynch charts
Reverse DCF
Relative Value

FAQ

What is Quest Diagnostics Incorporated intrinsic value?

As of Mar 03, 2025, Quest Diagnostics Incorporated Intrinsic Value is $369.8. This suggests it may be undervalued by 109.0% compared to its current price of around $177.0.

What is Quest Diagnostics Incorporated DCF (discounted cash flow) valuation?

As of Mar 03, 2025, Quest Diagnostics Incorporated's Discounted Cash Flow (DCF) valuation estimates its share price at $331.0. This suggests it may be overvalued by 87.1% to its current price of around $177.0, using a discount rate of 5.8% and terminal growth rate of 3.0%.

Is Quest Diagnostics Incorporated overvalued or undervalued?

Quest Diagnostics Incorporated is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $369.8, compared to a market price of around $177.0. This suggests a potential undervaluation of 109.0%.